Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019
August 22, 2019 at 11:41 am
Share
Harbin Medisan Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 1,126.418 million compared to CNY 995.440 million a year ago. Operating income was CNY 146.963 million compared to CNY 181.342 million a year ago. Net income was CNY 116.974 million compared to CNY 144.432 million a year ago. Basic earnings per share from continuing operations was CNY 0.37 compared to CNY 0.46 a year ago.
HARBIN MEDISAN PHARMACEUTICAL CO LTD is a China-based company principally engaged in the research and development, production and sales of chemical preparations, active pharmaceutical ingredients (APIs), medical devices and cosmetics. Its medicines cover the nervous system, cardio-cerebrovascular, systemic anti-infection, musculoskeletal, nutritional infusion, and body fluid balance infusion therapeutic fields. The Company's products include freeze-dried powder injections, small volume injections, large infusion products, solid preparations, medical devices and cosmetics. The Company mainly distributes its products within domestic market.
HARBIN MEDISAN PHARMACEUTICAL CO., LTD. 
